Advertisement

Topics

Bolder BioTechnology, Inc. Announces Initiation Of Phase I Clinical Trial Of BBT-015 For Treating Neutropenia And Acute Radiation Syndrome

20:00 EDT 1 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Bolder BioTechnology, Inc. Announces Initiation Of Phase I Clinical Trial Of BBT-015 For Treating Neutropenia And Acute Radiation Syndrome

NEXT ARTICLE

More From BioPortfolio on "Bolder BioTechnology, Inc. Announces Initiation Of Phase I Clinical Trial Of BBT-015 For Treating Neutropenia And Acute Radiation Syndrome"

Quick Search
Advertisement